E-poster No. / 壁報編號
C93
Title / 題目
Age-informed real-world evidence reveals TP53 mutation confers resistance to CDK4/6 but not immune checkpoint inhibitors in ER-positive/HER2-negative breast cancer
First Author / 第一作者
Masanori Oshi
Institution / 單位
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan
Audio / 音訊檔
Author Group / 作者群
Author Group Institution/ 作者群單位
Category / 主題分類
Clinical Research
Keyword / 關鍵字
TP53, CDK4/6 inhibitor, ICI, ER-positive/HER2-negative breast cancer